Teladoc Health Inc (TDOC) Shares Sold by Credit Suisse AG

Credit Suisse AG lowered its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 2.0% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 899,877 shares of the health services provider’s stock after selling 18,149 shares during the period. Credit Suisse AG’s holdings in Teladoc Health were worth $77,704,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Harvest Fund Management Co. Ltd acquired a new position in Teladoc Health in the third quarter worth about $165,000. National Asset Management Inc. acquired a new position in Teladoc Health in the third quarter worth about $224,000. We Are One Seven LLC acquired a new position in Teladoc Health in the third quarter worth about $225,000. Atria Investments LLC acquired a new position in Teladoc Health in the third quarter worth about $228,000. Finally, FineMark National Bank & Trust acquired a new position in Teladoc Health in the third quarter worth about $261,000.

In other news, CEO Jason N. Gorevic sold 25,000 shares of the stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $75.05, for a total transaction of $1,876,250.00. Following the sale, the chief executive officer now directly owns 536,184 shares of the company’s stock, valued at $40,240,609.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Lewis Levy sold 1,284 shares of the stock in a transaction that occurred on Monday, September 17th. The shares were sold at an average price of $77.00, for a total transaction of $98,868.00. Following the sale, the insider now directly owns 1,284 shares in the company, valued at $98,868. The disclosure for this sale can be found here. Insiders have sold 245,929 shares of company stock worth $17,142,945 over the last ninety days. Insiders own 3.95% of the company’s stock.

Shares of Teladoc Health stock opened at $55.75 on Friday. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of -33.79 and a beta of 0.96. Teladoc Health Inc has a 1-year low of $30.85 and a 1-year high of $89.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.02. The firm had revenue of $111.00 million for the quarter, compared to analysts’ expectations of $109.94 million. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The company’s quarterly revenue was up 61.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.55) earnings per share. As a group, equities analysts anticipate that Teladoc Health Inc will post -1.47 EPS for the current year.

Several research analysts recently issued reports on TDOC shares. TheStreet lowered shares of Teladoc Health from a “c” rating to a “d+” rating in a research report on Tuesday, October 9th. Craig Hallum increased their price target on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, October 15th. SunTrust Banks increased their price target on shares of Teladoc Health to $100.00 and gave the stock a “buy” rating in a research report on Monday, September 24th. Canaccord Genuity increased their price target on shares of Teladoc Health from $70.00 to $86.00 and gave the stock a “buy” rating in a research report on Thursday, September 20th. Finally, Jefferies Financial Group set a $95.00 price target on shares of Teladoc Health and gave the stock a “buy” rating in a research report on Friday, November 2nd. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $85.06.

WARNING: This article was originally published by WKRB News and is owned by of WKRB News. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.wkrb13.com/2018/11/25/teladoc-health-inc-tdoc-shares-sold-by-credit-suisse-ag.html.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: What are defining characteristics of a correction?

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply